Could ProKidney Corp (PROK) stock price achieve new all-time highs if its expected earnings and revenue increase?

In Wednesday’s Wall Street session, ProKidney Corp (NASDAQ:PROK) shares traded at $4.34, up 16.35% from the previous session.

PROK stock price is now 379.23% away from the 50-day moving average and 216.17% away from the 200-day moving average. The market capitalization of the company currently stands at $1.27B.

With the price target maintained at $1, BofA Securities recently Downgraded its rating from Neutral to Underperform for ProKidney Corp (NASDAQ: PROK). , while ‘Guggenheim’ rates the stock as ‘Buy’

In other news, Weber Darin J., Chief Regulatory Officer sold 103,480 shares of the company’s stock on Jul 08 ’25. The stock was sold for $312,510 at an average price of $3.02. Upon completion of the transaction, the Chief Regulatory Officer now directly owns 0 shares in the company, valued at $0.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 08 ’25, Officer DARIN J WEBER bought 103,480 shares of the business’s stock. A total of $62,761 was incurred on buying the stock at an average price of $0.61. A total of 27.29% of the company’s stock is owned by insiders.

During the past 12 months, ProKidney Corp has had a low of $0.46 and a high of $4.92. The fifty day moving average price for PROK is $0.90562 and a two-hundred day moving average price translates $1.372685 for the stock.

The latest earnings results from ProKidney Corp (NASDAQ: PROK) was released for 2025-03-31.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.